Assoc. Prof. Dr. Suray Pehlivanoglu | Necmettin Erbakan University | Turkey
Assoc. Prof. Dr. Suray Pehlivanoğlu is a distinguished molecular biologist and geneticist serving at Necmettin Erbakan University, Faculty of Science, Department of Molecular Biology and Genetics, Meram, Konya, Turkey. He holds a Ph.D. in Medical Genetics from Akdeniz University, where his doctoral work focused on TWIST1 transcription factor activation mechanisms and natural inhibitors, building upon his earlier master’s research on FGFR2 gene mutations in craniosynostosis. Dr. Pehlivanoğlu’s academic career spans over a decade, progressing from Research Assistant at Akdeniz University to Assistant Professor and now Associate Professor, where he supervises master’s and doctoral theses in cancer biology, immunogenetics, and molecular signaling. His research emphasizes cancer molecular biology, transcription factor regulation, hypoxia signaling, PAK4-mediated pathways, nanoparticle-based therapeutics, and regenerative medicine, with contributions to the development of novel anticancer agents and nanomaterials with targeted cytotoxic effects. He has been principal investigator and collaborator on numerous nationally funded projects, including studies on platelet-derived growth factor signaling, TWIST1 target gene transcriptomics, and biosynthesis of anticancer nanomaterials. Dr. Pehlivanoğlu has authored 35 peer-reviewed documents, accumulating 254 citations from 243 publications and maintaining an h-index of 10, reflecting the impact and consistency of his scientific contributions. He has published widely in international journals such as Molecular and Cellular Endocrinology, Journal of Cellular and Molecular Medicine, and 3 Biotech, and contributed chapters to scientific books on neuroplasticity, craniosynostosis, and stem cell applications. His innovative work has earned several honors, including oral presentation awards and recognition for excellence in cancer biology research. Actively engaged in mentoring young researchers, he continues to explore molecular mechanisms of tumor progression, hypoxia response, and immune modulation, aiming to translate his findings into novel therapeutic strategies and clinical applications.
Featured Publications
Sarigüney, B., Karakaş Sarikaya, E., & Pehlivanoğlu, S. (2024). Determining stable structure and in vitro antiproliferative properties of a novel 3-(2-((4-trifluoromethyl)phenyl)amino)thiazol-4-yl)-2H-chromen-2-one molecule. Chemistry & Biodiversity.
Acar, C. A., Gencer, M. A., Pehlivanoglu, S., Yesilot, S., & Donmez, S. (2024). Green and eco-friendly biosynthesis of zinc oxide nanoparticles using Calendula officinalis flower extract: Wound healing potential and antioxidant activity. International Wound Journal.
Acar, C. A., Pehlivanoglu, S., Yesilot, S., & Yakut Uzuner, S. (2023). Microwave-assisted biofabrication of silver nanoparticles using Helichrysum arenarium flower extract: Characterization and biomedical applications. Biomass Conversion and Biorefinery.
Findik, M., Türkkan, E., Pehlivanoglu, S., Sayin, U., Ceylan, U., & Akgemci, E. G. (2023). New copper(II) complex based-thiosemicarbazone and phenanthroline: DNA/BSA binding, antiproliferative activity, DFT and docking studies. Inorganic Chemistry Communications, 154, 111300.
Findik, M., Kuzu, B., Pehlivanoglu, S., Kaya, S., Sayin, U., Guler Akgemci, E., & Saf, A. O. (2023). Synthesis of carbazole-substituted thiosemicarbazone and its Cu(II) complex, DNA/protein binding, cytotoxic, antiproliferative activities and molecular docking studies. Inorganic Chemistry Communications, 152, 110711.